116
Participants
Start Date
July 1, 2020
Primary Completion Date
March 30, 2024
Study Completion Date
March 30, 2024
Rituximab
To evaluate the efficacy and safety of HLX01 combined with RASi in patients with IgAN.
RAS 2410
To evaluate the efficacy and safety of RASi in patients with IgAN.
Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai
Dongfang Hospital Affiliated to Tongji University
OTHER
Shanghai Pudong New Area People's Hospital
OTHER
Ruijin Hospital North Shanghai Jiao Tong University School of Medicine
UNKNOWN
Ningbo Municipal Yinzhou District No.2 Hospital
OTHER
Third Affiliated Hospital, Sun Yat-Sen University
OTHER
Xiamen Hong'ai Hospital
UNKNOWN
Sir Run Run Shaw Hospital
OTHER
Tongji Hospital
OTHER
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
Nan Chen,MD
OTHER